Latest News in the pharma Industry

Top Stories

European Medicines Agency clarifies rules on fees

European Medicines Agency clarifies rules on fees

17 Sep 2012

The European Medicines Agency has revised the rules on fees payable to the Agency.

Read more 
Stella Blackburn appointed president of the International Society for Pharmacoepidemiology

Stella Blackburn appointed president of the International Society for Pharmacoepidemiology

17 Sep 2012

The European Medicines Agency congratulates Dr Stella Blackburn, the Agency's Risk Management Development and Scientific Lead, for her appointment as president of the International Society for Pharmacoepidemiology (ISPE).

Read more 
Pharmacovigilance Risk Assessment Committee (PRAC) elects chair and vice-chair

Pharmacovigilance Risk Assessment Committee (PRAC) elects chair and vice-chair

17 Sep 2012

The European Medicines Agency’s recently established Pharmacovigilance Risk Assessment Committee (PRAC) has elected June Raine (pictured) from the United Kingdom (UK) as its chair and álmath Spooner from Ireland as its vice-chair at its second mee...

Read more 
Big Pharma Fights Drug Rulings In India

Big Pharma Fights Drug Rulings In India

17 Sep 2012

Landmark drug patent protection cases involving Bayer, Roche, and Novartis are advancing in India this month. Together, they will help determine how friendly the country is to Western pharmaceutical makers.

Read more 
AESICA ANNOUNCES KEY NORTH AMERICAN APPOINTMENT

AESICA ANNOUNCES KEY NORTH AMERICAN APPOINTMENT

14 Sep 2012

One of Europe’s leading CMOs, Aesica, has announced a key addition to its commercial team as it looks to strengthen its position in North America.

Read more 
Possible therapy for tamoxifen-resistant breast cancer identified

Possible therapy for tamoxifen-resistant breast cancer identified

6 Sep 2012

A study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has discovered how tamoxifen-resistant breast-cancer cells grow and proliferate.

Read more 
Pfizer leukaemia drug receives US approval

Pfizer leukaemia drug receives US approval

6 Sep 2012

The US Food and Drug Administration has approved Pfizer's Bosulif, used to treat a rare type of leukaemia usually suffered by older adults.

Read more 
FDA questions efficacy of Novartis cystic fibrosis drug tobramycin

FDA questions efficacy of Novartis cystic fibrosis drug tobramycin

6 Sep 2012

The US Food and Drug Administration has questioned the efficacy of Novartis' experimental cystic fibrosis drug tobramycin ahead of an advisory panel meeting this week.

Read more 
Biotage Unveils New Fully Automated Microwave Peptide Synthesizer

Biotage Unveils New Fully Automated Microwave Peptide Synthesizer

4 Sep 2012

Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, introduced an innovative new synthesis platform for peptide researchers at the 2012 European Peptide Symposium in Athens, Greece...

Read more 
Majority of pharma firms have in-house companion diagnostics staff

Majority of pharma firms have in-house companion diagnostics staff

27 Aug 2012

Many companies now have people working full-time on companion diagnostics for use alongside targeted therapies.

Read more 
Pfizer and Mylan announce generics collaboration in Japan

Pfizer and Mylan announce generics collaboration in Japan

27 Aug 2012

A new partnership between Pfizer and Mylan should help to drive generic utilisation in Japan.

Read more 
Pharma companies spend over $30m on global MSL teams

Pharma companies spend over $30m on global MSL teams

27 Aug 2012

Cutting Edge Information has shed light on pharmaceutical companies' MSL spend.

Read more